Cryptolepine and Nibima inhibit hepatitis B virus replication

Cryptolepine and Nibima inhibit hepatitis B virus replication

The continuous use of interferons (IFNs) in patients with chronic hepatitis B virus (HBV) infection leads to myriad adverse effects. Also, in sub-Saharan Africa where chronic HBV infection is endemic, pegylated IFN-α and tenofovir disoproxil fumarate, which are first-line agents in the treatment of...

Full description

Bibliographic Details
Main Authors: Seth  A. Domfeh, Patrick  W. Narkwa, Osbourne Quaye, Kwadwo  A. Kusi, Odalys Rivera, Martin  M. Danaah, Baba  A.N. Musah, Gordon  A. Awandare, Kwesi  B. Mensah, Mohamed Mutocheluh
Format: Article
Language:English
Published: Elsevier 2021-09-01
Series:Scientific African
Subjects:
Nibima
Cryptolepine
Antiviral activity
Viral load
Hepatitis B virus
Online Access:http://www.sciencedirect.com/science/article/pii/S2468227621002465

Internet

http://www.sciencedirect.com/science/article/pii/S2468227621002465

Similar Items